eScholarship
metadata only
Characterization of the HIV-1 transcription profile after romidepsin administration in ART-suppressed individuals
OBJECTIVES: Reversing HIV-1 latency has been suggested as a strategy to eradicate HIV-1. We investigated the effect of romidepsin on the HIV transcription profile in participants from the REDUC part B clinical trial. DESIGN: Seventeen participants on suppressive antiretroviral therapy were vaccinate
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir#1058337
- A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients#1362144
- Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen#1046548
- Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir#1163358
- A Trial of Vitamins and HAART in HIV Disease Progression#838942
Record · ID 1250024
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive